22ndWorld Congress on Psychosomatic Medicine VE Medvedev Neurology, Neuropsychiatry, Psychosomatics 5 (4), 94-96, 2013 | | 2013 |
A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders VE Medvedev, ON Tereshchenko, I AIu, IK Chobanu, NV Kost, S OIu, ... Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 114 (7), 17-22, 2014 | 5 | 2014 |
Agomelatine (Valdoxan) in treatment of endogenous depression in day patient department EV Chernova, OV Kozhechkina, AY Ter-Israelyan, VE Medvedev Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 116 (10), 43-46, 2016 | 5 | 2016 |
Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE VE Medvedev Neuropsychiatric disease and treatment, 1141-1151, 2017 | 29 | 2017 |
Alimemazine in psychiatry and psychosomatics VE Medvedev Psikhiatriya i psikhofarmakoterapiya im. PB Gannushkina 20 (3-4), 26-33, 2018 | 6 | 2018 |
Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs EA Ushkalova, SK Zyryanov, KE Zatolochina, AP Pereverzev, ... Rational Pharmacotherapy in Cardiology 12 (4), 471-478, 2016 | 3 | 2016 |
Antidepressant therapy in patients with cardiovascular diseases VE Medvedev, EA Korovyakova, VI Frolova, EV Gushanskaya Neurology, Neuropsychiatry, Psychosomatics 11 (1), 131-140, 2019 | 9 | 2019 |
Anxiety and depression in COVID-19: treatment options VE Medvedev Neurology, Neuropsychiatry, Psychosomatics 13 (2), 111-116, 2021 | 10 | 2021 |
Assessment of the efficacy and tolerability of melatonergic antidepressant treatment in patients surgical correction of the appearance VÉ Medvedev, TV Barsegian Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 114 (11 Pt 2), 3-9, 2014 | | 2014 |
Astenic disorders within the framework of post-covid syndrome VE Medvedev, VI Frolova, EV Gushanskaya, OV Kotova, NL Zuikova, ... Zhurnal Nevrologii i Psikhiatrii imeni SS Korsakova 121 (4), 152-158, 2021 | 9 | 2021 |
Augmented antipsychotic therapy with pantogam active in patients with schizophrenia VE Medvedev, VI Frolova, EV Gushanskaya, AU Ter-Israelyan Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 115 (8), 28-34, 2015 | | 2015 |
Causeless appearance discontentment in patients of plastic surgeons and cosmetologists: Risk factors and patterns of dynamics V Medvedev, V Frolova European Psychiatry 41 (S1), s497-s497, 2017 | 1 | 2017 |
Clinical and psychosomatic peculiarities of essential hypertension under the conditions of chronic stress K FIu, AL Syrkin, D MIu, SA Virusov, VE Medvedev Klinicheskaia Meditsina 86 (2), 23-26, 2008 | 1 | 2008 |
Clinical aspects of the use of imidazopyridine derivatives in the treatment of sleep disorders associated with post-COVID syndrome OV Kotova, EV Tsareva, VE Medvedev, AA Belyaev, EV Gushanskaya, ... Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 122 (12), 39-44, 2022 | | 2022 |
Combined therapy of neurasthenia in general medical practice OR Dobrushina, VE Medvedev Consilium Medicum 18 (2), 95-99, 2016 | 3 | 2016 |
Contemporary mental health care models and mental disorders treatment strategies VE Medvedev, VI Frolova, RA Kardashyan The Russian Archives of Internal Medicine, 73-78, 2015 | 2 | 2015 |
Correlations between doctors’ and patients’ assessment of depression’severity and efficacy of treatment V Medvedev, K Retyunsky, A Ovchinnikov, Y Barilynik, A Shmilovich, ... European Psychiatry 41 (S1), S534-S534, 2017 | | 2017 |
COVID-19 and mental health: challenges and first conclusions VE Medvedev, OA Dogotar Neurology, neuropsychiatry, psychosomatics 12 (6), 4-10, 2020 | 22 | 2020 |
COVID-19 and mental health: Challenges and first conclusions [COVID-19 и психическое здоровье: вызовы и первые выводы] V Medvedev, O Dogotar | | 2021 |
COVID-19 and stress-related disorders OV Kotova, VE Medvedev, ES Akarachkova, AA Belyaev Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova 121 (5. Vyp. 2), 122-128, 2021 | 11 | 2021 |